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1 |  INTRODUCTION
Growth in the areas of new enzyme discovery and develop-
ment of novel biocatalytic reactions, combined with advances 
in protein engineering strategies, have positioned biocatalysis 
to have a greater footprint in synthetic chemistry (Rudroff 
et al., 2018; Sheldon & Woodley, 2018). Biocatalytic meth-
ods also provide green alternatives to traditional chemical 
reactions by avoiding the use of organic solvents, minimiz-
ing hazardous waste streams, and using abundant materi-
als (Sheldon & Woodley, 2018). However, the adoption of 
biocatalytic methods relies on the development of scalable, 
economical, and operationally accessible reaction platforms. 
Recently, significant effort has been dedicated to establishing 
efficient biocatalytic reaction platforms for a wide variety of 
transformations. A number of approaches have been devel-
oped for conducting preparative- scale biocatalytic reactions, 
including reactions with purified enzymes, crude cell lysates 
(Rudroff et al., 2018; Sheldon & Woodley, 2018) immobi-
lized enzymes (Liang, Li, & Yang, 2000; Sheldon & van Pelt, 
2013; Soares et al., 2011) lyophilized lysates, and wet whole 
cells (de Carvalho, 2017; Lin & Tao, 2017; Wachtmeister, 
Mennicken, Hunold, & Rother, 2016). Enzymes in various 
forms can be employed in batch or flow reactors (Britton, 
Majumdar, & Weiss, 2018; Tamborini, Fernandes, Paradisi, 
& Molinari, 2018). Whole- cell (WC) transformations present 
several advantages over using isolated enzymes for in vitro 
reactions. For example, supply costs associated with the gen-
eration of WC preparations are much lower than for isolated 
proteins. Specifically, the cost of affinity chromatography 
resins, protein concentration devices, and cell lysis equip-
ment is avoided for WC methods. WC preparations are also 
less time intensive, as laborious protein purification steps are 
not required. Similarly, crude cell lysate preparations also 
avoid a full protein purification, capturing some of these 
advantages. These attributes make WC biocatalysts more 
accessible to chemists and help promote the broader use of 
biocatalysts in organic synthesis. Capitalizing on these advan-
tages, the use of WC biocatalysis for chemical synthesis has 
become increasingly prevalent in both academic and indus-
trial settings (Bommarius, 2015; Bornscheuer et al., 2012; de 
Carvalho, 2017; Li et al., 2016; Parmeggiani, Weise, Ahmed, 
& Turner, 2018; Schrittwieser, Velikogne, Hall, & Kroutil, 
2018; Wachtmeister & Rother, 2016). Recently, Flitsch and 
Turner reported a WC biocatalytic process for the stereose-
lective amination of benzylic C–H bonds (Both et al., 2016). 
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Abstract
Technologies enabling new enzyme discovery and efficient protein engineering have 
spurred intense interest in the development of biocatalytic reactions. In recent years, 
whole- cell biocatalysis has received attention as a simple, efficient, and scalable bio-
catalytic reaction platform. Inspired by these developments, we have established a 
whole- cell protocol for oxidative dearomatization of phenols using the flavin- 
dependent monooxygenase, TropB. This approach provides a scalable biocatalytic 
platform for accessing gram- scale quantities of chiral synthetic building blocks.
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This feat was accomplished by co- transforming two plasmids 
containing genes corresponding to four enzymes necessary 
for a biocatalytic cascade (a monooxygenase, two alcohol de-
hydrogenases, and a ω- transaminase, Figure 1b). By incubat-
ing the reaction components with the requisite biocatalysts in 
WC form in a sealed reaction vessel, they were able to pro-
duce chiral amines (8) with moderate yields and high enanti-
oselectivity. Without a WC biocatalytic platform, this process 
would have been logistically cumbersome, requiring the ex-
pression and potential isolation of each enzyme individually.
On an industrial scale, several processes have been de-
signed to employ WC biocatalysts. Notably, WC biocataly-
sis has been utilized for the generation of valuable chemical 
feedstocks such as enantio- enriched alcohols, (Matsuyama, 
Yamamoto, & Kobayashi, 2002) performance material 
monomers, (Kaluzna et al., 2016) and pharmaceutically rele-
vant intermediates, (Guo et al., 2017) as well as the late- stage 
functionalization of active pharmaceutical ingredients during 
route development (Figure 1a; Guo et al., 2017; Milker, 
Fink, Rudroff, & Mihovilovic, 2017; Xie & Tang, 2007). 
Recently, researchers at GlaxoSmithKline demonstrated that 
a WC biocatalysis platform is also useful for discovery of 
new synthetic routes on the gram- scale, developing several 
biocatalytic routes to chiral 1,3- substituted cyclohexanones, 
such as 2 (Hadi et al., 2018). After obtaining initial hits from 
enzyme libraries, the use of WC biocatalysts allowed the 
GlaxoSmithKline team to rapidly scale reactions and ulti-
mately provide the desired chiral cyclohexanone products in 
gram quantities.
We previously established a platform for WC bio-
catalytic oxidative dearomatization of phenols using the 
flavin- dependent monooxygenase TropB (Baker Dockrey, 
Lukowski, Becker, & Narayan, 2018). The native biosyn-
thetic function of TropB was first characterized by Cox and 
coworkers in 2012 (Abood et al., 2015; Davison et al., 2012). 
TropB is an oxygenase, involved in the biosynthesis of stip-
itatic acid, that naturally converts 3- methyl- orcinaldehyde 
(9) to dienone 10 with perfect site- and stereoselectivity 
(Figure 2) (Abood et al., 2015; Baker Dockrey et al., 2018; 
Davison et al., 2012). We have previously demonstrated that 
TropB possesses a broad substrate scope and is able to gener-
ate a diverse array of dienone products (Baker Dockrey et al., 
2018). The products generated through this powerful reac-
tion can serve as building blocks to valuable bioactive nat-
ural products, including tropolones and azaphilones (Abood 
et al., 2015; Baker Dockrey et al., 2018; Davison et al., 2012; 
Gao, Yang, & Qin, 2013). Over the last two decades, several 
chemical reagents have been developed to affect this difficult 
transformation (Bosset et al., 2014; Roche & Porco, 2011; 
Volp & Harned, 2013; Wu, Zhang, & You, 2016; Zhu, 
Grigoriadis, Lee, & Porco, 2005). Despite advances in 
synthetic oxidative dearomatization methodology, these 
F I G U R E  1  Examples of WC biocatalytic processes. (a) Select scaffolds accessed through WC biocatalytic reactions (Baker Dockrey et al., 
2018; Guo et al., 2017; Hadi et al., 2018; Kaluzna et al., 2016; Matsuyama et al., 2002; Milker et al., 2017; Xie & Tang, 2007). (b) WC biocatalysis 
utilizing a multi- enzyme cascade to generate chiral benzylic amines (Both et al., 2016) [Colour figure can be viewed at wileyonlinelibrary.com]
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reactions often exhibit substrate- controlled site- selectivity, 
low levels of stereoselectivity, and can require stoichiometric 
chiral reagents. In contrast, Nature has conquered this reac-
tion by using common biochemical cofactors and molecular 
oxygen, along with an evolved active site to provide impecca-
ble site- and stereoselectivity. The advantages of biocatalytic 
oxidative dearomatization inspired our interest in developing 
TropB as a synthetically useful catalyst.
Flavin- dependent monooxygenases employ the non- 
covalent cofactor flavin adenine dinucleotide (FAD, 12), 
which following reduction to FADH2 (14) can react with mo-
lecular oxygen to form C4- α- hydroperoxyflavin 15 (Figure 3) 
(Ullrich & Hofrichter, 2007). This highly reactive species 
serves as an electrophilic source of oxygen for the oxidative 
dearomatization of electron- rich phenolic substrates. In the 
final step, loss of water from 17 regenerates FAD to close the 
catalytic cycle. We initially recognized that the requirement 
for stoichiometric NADPH is a potentially limiting factor in 
the scalability of this reaction. To address this limitation, 
we employed a well- established NADPH recycling system. 
Using this system, cofactor recycling could be successfully 
integrated into our WC reactions with native and non- native 
substrates on gram- scale to obtain complete conversion of 
substrates to dearomatized products (Baker Dockrey et al., 
2018).
Our platform for WC reactions utilizes well- established 
biochemical tools to rapidly generate biocatalyst in high 
quantities (Figure 4). The general workflow begins with 
transformation of an expression plasmid containing the target 
gene, tropB, into E. coli BL21(DE3) cells, followed by over-
expression of TropB in nutrient- rich media. After harvesting 
and flash- freezing the cells containing TropB, these cells can 
F I G U R E  2  Native reactivity of TropB within the stipitatic acid (11) biosynthetic pathway [Colour figure can be viewed at wileyonlinelibrary.
com]
F I G U R E  3  Proposed catalytic cycle of type A flavin- dependent monooxygenases in oxidative dearomatization of phenolic substrates (Ullrich 
& Hofrichter, 2007) [Colour figure can be viewed at wileyonlinelibrary.com]
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be immediately used for oxidative dearomatization reactions. 
In contrast, obtaining protein for in vitro reactions requires 
several additional steps beyond protein expression, including 
cell lysis, purification by immobilized metal affinity chroma-
tography, and desalting procedures. Thus, WC methods sig-
nificantly decrease the time and resources required to prepare 
the catalyst for use in reactions.
The workflow employed for WC biocatalysis included the 
following steps. A gene, codon- optimized for heterologous 
expression in E. coli, was synthesized and cloned into pET- 
151 by GeneArt (ThermoFisher). The plasmid DNA was 
transformed into chemically competent E. coli BL21(DE3) 
by standard heat- shock technique. An individual colony was 
selected and grown overnight in a 5- ml culture of LB media 
supplemented with ampicillin for plasmid maintenance. A 
500- ml culture of sterilized Terrific Broth was supplemented 
with ampicillin and inoculated with 5 ml of overnight cul-
ture. This culture was incubated at 37°C until the cell den-
sity (OD600) reached 0.6–0.8, at which point the culture was 
cooled to 20°C and protein overexpression was induced by 
addition of IPTG (0.1 mM final concentration). The culture 
was incubated at 20°C for 14–16 hr before harvesting the 
cells via centrifugation (4,000 × g for 20 min).
Two methods were used to prepare the cell pellet for use 
in WC reactions: flash- freezing or lyophilization. For the for-
mer, the crude cell pellet was flash frozen in liquid nitrogen 
in small aliquots. This method greatly alleviated difficulties 
in weighing out wet cell pellet for accurate quantification of 
our WC reactions. For the preparation of lyophilized cells, the 
crude cell pellet was aliquoted into 1 gram portions and re-
suspended in an excipient solution (0.5 L, 10% w/v excipient 
in Milli- Q water) and pelleted in several 50 ml Falcon tubes. 
The tubes were then covered with a KimWipe and lyophilized 
for 48–72 hr. To identify the ideal preparation method for ly-
ophilized cell pellet for use in our WC reactions, we added 
various excipients to cells prior to lyophilization based upon 
a survey of common excipients used in the literature (Baheti, 
Kumar, & Bansal, 2010; Bedu- Addu, 2004; Randolph, 1997). 
We then compared the activity of each preparation in 1 g scale 
reactions with the non- native substrate 18 (Table 1). The re-
sults of these experiments indicated that enzyme activity was 
maintained in lyophilized cells, and only improved nominally 
by the addition of 10 wt % sucrose or PEG 4000 (entries 3 
and 4, respectively) (Baheti et al., 2010; Bedu- Addu, 2004; 
Randolph, 1997). This method simplified the handling of the 
biocatalytic reagent, streamlining the set- up of large- scale 
reactions.
Preparative- scale WC enzymatic reactions were con-
ducted on 1 g of substrate under the following conditions: 20 
weight equivalents of wet cell pellet, 5 mM substrate, 10% 
(v/v) toluene (caution: highly flammable solvent), 0.1 mM 
NADP+, 0.1 U/ml glucose- 6- phosphate dehydrogenase 
(G6PDH), and 10 mM glucose- 6- phosphate for NADPH gen-
eration in reaction buffer (50 mM potassium phosphate buf-
fer, pH 8.0). The reaction components were combined in a 1 L 
Erlenmeyer flask and incubated at 30°C for 2 hr at 100 rpm. 
The reaction mixture was filtered through Celite, acidified 
to pH 2.0 and extracted with ethyl acetate (3 × 500 ml). The 
F I G U R E  4  Workflow of whole- cell reaction versus purified enzyme for TropB biocatalysis. Plasmid containing tropB is transformed into E. 
coli and then expressed. E. coli cells harboring TropB are harvested by centrifugation and frozen. The pellet can be added directly to the reaction 
flask. Additional steps are required to prepare purified protein [Colour figure can be viewed at wileyonlinelibrary.com]
T A B L E  1  Optimization of gram- scale reactions with lyophilized 
cell pellet
Entry Excipient % conversion
1 No additive 98
2 10 wt% skim milk 83
3 10 wt% sucrose >99
4 PEG 4000 >99
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combined organic layers were dried over sodium sulfate, fil-
tered and concentrated under reduced pressure. The resulting 
mixture was purified on silica gel (methanol/acetic acid/di-
chloromethane, 1:1:10) to afford the o- quinol product. For 
smaller scale reactions (5 mg), the same procedure was em-
ployed, except a 100- ml Erlenmeyer flask was used in place 
of a 1 L flask. To monitor reaction progress, 50 μl aliquots 
were removed from the reaction and quenched with 75 μl of 
methanol supplemented with an internal standard, 2.5 mM 
pentamethyl benzene. Reaction conversion was monitored 
by UPLC- DAD, and starting material consumption was 
quantified by comparison with a substrate calibration curve 
(Figure 5).
2 |  RESULTS AND DISCUSSION
Whole- cell reactions with TropB were initially performed in 
aqueous buffer alone. Under these conditions, conversions 
of starting material were low, which we hypothesized was 
due to poor substrate solubility in the aqueous reaction en-
vironment. To resolve this issue, we tested the effect of both 
water- miscible and immiscible solvents on the WC reac-
tion (Table 2). Toluene improved conversion to dienone 10, 
with full conversion in 2 hr under the described conditions. 
Additionally, we screened reactions with a reduced amount 
of wet cells and noted complete conversion with cell loading 
as low as 20 weight equivalents. These optimized conditions 
were applied to gram- scale reactions, further demonstrating 
the appeal of this method for synthetic applications.
Using our optimized WC biocatalysis platform, the over-
all yield of usable biocatalyst from each protein expression 
was significantly higher than what was obtained following 
protein purification for in vitro reactions. In this case, more 
than 20 WC preparative- scale (100 mg) reactions could be 
carried out for every liter of TropB expression cell culture. 
In comparison, from 1 L of expression culture, the quan-
tity of purified protein was sufficient for 2–3 reactions on 
the same scale (Table 3). We suspect this was due to a loss 
of protein and activity over the course of the purification 
procedure. Reactions carried out with crude cell lysate gave 
diminished conversions relative to both in vitro and WC re-
actions, indicating that some enzyme stabilization may have 
been provided by the cellular environment. The WC biocat-
alyst also required significantly less time to prepare, saving 
5–6 hr for each batch of catalyst. Therefore, our WC plat-
form demonstrated superior efficiency over in vitro reac-
tions in both preparation time and scalability of the reaction.
3 |  CONCLUSIONS
In summary, we have developed a scalable and economi-
cal WC biocatalytic method for oxidative dearomatization 
of phenols. This biocatalytic method improves upon pre-
viously developed chemical methods in terms of environ-
mental sustainability, as it uses water as a solvent and a 
renewable biological catalyst as the oxidant. In comparison 
with in vitro reactions, WC biocatalytic methods can pro-
vide distinct and significant advantages. With no require-
ment for enzyme purification, WC procedures reduce the 
overall time, cost and specialized equipment associated 
with catalyst production. After the simple optimization of 
several parameters, such as cell preparation method and 
reaction co- solvent, our WC platform allowed us to per-
form tenfold more reactions per liter of cell culture when 
F I G U R E  5  UPLC trace for oxidative dearomatization of 9 by 
TropB [Colour figure can be viewed at wileyonlinelibrary.com]








1 500 No co- solvent 23
2 500 Ethanol 54
3 500 Acetonitrile <5
4 500 Methanol 62
5 500 Tetrahydrofuran <5
6 500 Toluene >99
7 100 Toluene >99
8 50 Toluene 86
T A B L E  3  Scalability of WC platform compared to in vitro 
platform
Platform Scale of reactions (mg)
Reactions per 
liter cell culture
In vitro 100 2–3
WC 100 >20
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compared to purified enzyme. This improvement was 
achieved without loss of catalytic function or selectivity. 
Moreover, this highly scalable method provides a simple 
and accessible reaction platform, promoting use of biocata-
lysts in synthetic chemistry.
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